These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 28356334)

  • 1. Clinical Applications of Circulating Tumor Cells in Pharmacotherapy: Challenges and Perspectives.
    Wu T; Cheng B; Fu L
    Mol Pharmacol; 2017 Sep; 92(3):232-239. PubMed ID: 28356334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumor cells (CTCs) as a liquid biopsy material and drug target.
    Cai LL; Ye HM; Zheng LM; Ruan RS; Tzeng CM
    Curr Drug Targets; 2014; 15(10):965-72. PubMed ID: 25182470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Applications of and Challenges in Single-Cell Analysis of Circulating Tumor Cells.
    Wu CP; Wu P; Zhao HF; Liu WL; Li WP
    DNA Cell Biol; 2018 Feb; 37(2):78-89. PubMed ID: 29265876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy.
    Alix-Panabières C; Pantel K
    Cancer Discov; 2016 May; 6(5):479-91. PubMed ID: 26969689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Tumor Cells as Cancer Biomarkers in the Clinic.
    Chinen LTD; Abdallah EA; Braun AC; Flores BCTCP; Corassa M; Sanches SM; Fanelli MF
    Adv Exp Med Biol; 2017; 994():1-41. PubMed ID: 28560666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fugitives on the run: circulating tumor cells (CTCs) in metastatic diseases.
    Mamdouhi T; Twomey JD; McSweeney KM; Zhang B
    Cancer Metastasis Rev; 2019 Jun; 38(1-2):297-305. PubMed ID: 31053984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating tumor cells as promising novel biomarkers in solid cancers.
    Lianidou ES; Strati A; Markou A
    Crit Rev Clin Lab Sci; 2014 Jun; 51(3):160-71. PubMed ID: 24641350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiling circulating tumour cells and other biomarkers of invasive cancers.
    Poudineh M; Sargent EH; Pantel K; Kelley SO
    Nat Biomed Eng; 2018 Feb; 2(2):72-84. PubMed ID: 31015625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumor cells as a promising target for individualized drug susceptibility tests in cancer therapy.
    Smit DJ; Pantel K; Jücker M
    Biochem Pharmacol; 2021 Jun; 188():114589. PubMed ID: 33932470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional studies on circulating and disseminated tumor cells in carcinoma patients.
    Alix-Panabières C; Bartkowiak K; Pantel K
    Mol Oncol; 2016 Mar; 10(3):443-9. PubMed ID: 26847851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating tumour cells in cancer patients: challenges and perspectives.
    Pantel K; Alix-Panabières C
    Trends Mol Med; 2010 Sep; 16(9):398-406. PubMed ID: 20667783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of circulating tumor cells-from bench to bedside.
    Li Y; Wu S; Bai F
    Semin Cell Dev Biol; 2018 Mar; 75():88-97. PubMed ID: 28899718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Circulating tumor cells: liquid biopsy].
    Alix-Panabières C; Pierga JY
    Bull Cancer; 2014 Jan; 101(1):17-23. PubMed ID: 24445939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of CTCs as Tumor Biomarkers.
    Lianidou ES; Markou A; Strati A
    Adv Exp Med Biol; 2015; 867():341-67. PubMed ID: 26530376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EMT, CTCs and CSCs in tumor relapse and drug-resistance.
    Mitra A; Mishra L; Li S
    Oncotarget; 2015 May; 6(13):10697-711. PubMed ID: 25986923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumor cells in lung cancer.
    Young R; Pailler E; Billiot F; Drusch F; Barthelemy A; Oulhen M; Besse B; Soria JC; Farace F; Vielh P
    Acta Cytol; 2012; 56(6):655-60. PubMed ID: 23207444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating tumor cells in breast cancer: applications in personalized medicine.
    Lee JS; Magbanua MJM; Park JW
    Breast Cancer Res Treat; 2016 Dec; 160(3):411-424. PubMed ID: 27761678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating tumor cells: a multifunctional biomarker.
    Yap TA; Lorente D; Omlin A; Olmos D; de Bono JS
    Clin Cancer Res; 2014 May; 20(10):2553-68. PubMed ID: 24831278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motion.
    Wang H; Stoecklein NH; Lin PP; Gires O
    Oncotarget; 2017 Jan; 8(1):1884-1912. PubMed ID: 27683128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tumor cells in breast cancer--current status and perspectives.
    Banys-Paluchowski M; Krawczyk N; Meier-Stiegen F; Fehm T
    Crit Rev Oncol Hematol; 2016 Jan; 97():22-9. PubMed ID: 26563820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.